Noxafil and Actigall drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Noxafil (posaconazole) and Actigall (ursodiol). Common drug interactions include blood alkaline phosphatase increased among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Noxafil and Actigall. It is created by eHealthMe based on reports of 54 people who take the same drugs from the FDA, and is updated regularly.

What is Noxafil?

Noxafil has active ingredients of posaconazole. eHealthMe is studying from 5,919 Noxafil users. Check the latest studies of Noxafil.

What is Actigall?

Actigall has active ingredients of ursodiol. It is often used in gallstones. eHealthMe is studying from 2,162 Actigall users. Check the latest studies of Actigall.



On Jul, 17, 2026

54 people who take Noxafil and Actigall together, and have interactions are studied.

Noxafil and Actigall drug interactions.

What are the common drug interactions of Noxafil and Actigall, by gender? *:

female:

  1. Blood alkaline phosphatase increased
  2. Blood bilirubin increased
  3. Cardiac failure congestive
  4. Cellulitis (infection under the skin)
  5. Chronic hepatic failure (long lasting liver failure)
  6. Coagulopathy (blood's ability to clot is impaired)
  7. Constipation
  8. Cough
  9. Cytomegalovirus viraemia (cytomegalo virus in blood stream)
  10. Decreased appetite

male:

  1. Pneumonia
  2. Diarrhoea
  3. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  4. Death
  5. Failure to thrive (inadequate weight gain and physical growth in children)
  6. Fall
  7. Febrile neutropenia (fever with reduced white blood cells)
  8. Ileus (a painful obstruction of the ileum or other part of the intestine)
  9. Lung infection
  10. Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Noxafil and Actigall, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Back pain
  2. Headache (pain in head)
  3. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
  4. Hypotension (abnormally low blood pressure)

10-19:

n/a

20-29:

  1. Nausea (feeling of having an urge to vomit)
  2. Cytomegalovirus viraemia (cytomegalo virus in blood stream)
  3. Dehydration (dryness resulting from the removal of water)
  4. Headache (pain in head)
  5. Hypophagia (reduced food intake)
  6. Lactic acidosis (low ph in body tissues)
  7. Oral herpes (viral infection of mouth)
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Poor peripheral circulation
  10. Staphylococcal infection (an infection with staphylococcus bacteria)

30-39:

  1. Cardiac failure congestive
  2. Death
  3. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Multi-organ failure (multisystem organ failure)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Acute graft versus host disease in liver (acute complication in liver following an allogeneic tissue/blood transplant)
  8. Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
  9. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  10. Eye disorder

40-49:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Acinetobacter bacteraemia (infection of bacteria)
  3. Anaemia (lack of blood)
  4. Blood albumin decreased
  5. Blood alkaline phosphatase increased
  6. Blood calcium decreased
  7. Blood lactate dehydrogenase increased
  8. Blood potassium decreased
  9. Blood pressure decreased
  10. Blood urea increased

50-59:

  1. Leukaemia recurrent (repeat cancer of bone marrow or blood cells)
  2. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  3. Muscular weakness (muscle weakness)
  4. Night sweats (sweating in night)
  5. Pneumonia
  6. Pyrexia (fever)
  7. Rash
  8. Stomatitis (inflammation of mucous membrane of mouth)
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Alopecia (absence of hair from areas of the body)

60+:

  1. Vomiting
  2. Diarrhoea
  3. Platelet count decreased
  4. Alanine aminotransferase increased
  5. Atelectasis (partial or complete collapse of the lung)
  6. Blood alkaline phosphatase increased
  7. Blood bilirubin increased
  8. Cardiac arrest
  9. Cellulitis (infection under the skin)
  10. Chronic hepatic failure (long lasting liver failure)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 16 people, 29.63%
  2. Nausea And Vomiting: 13 people, 24.07%
  3. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 10 people, 18.52%
  4. Pain: 8 people, 14.81%
  5. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 7 people, 12.96%
  6. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 7 people, 12.96%
  7. Constipation: 5 people, 9.26%
  8. Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 5 people, 9.26%
  9. Viral Infection: 4 people, 7.41%
  10. Graft Versus Host Disease In Skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin): 4 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Noxafil and Actigall?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Noxafil and Actigall:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Noxafil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Actigall:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Noxafil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Actigall and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on posaconazole and ursodiol (the active ingredients of Noxafil and Actigall, respectively), and Noxafil and Actigall (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: